טוען...
The prevalence of PAI-1 4G/5G polymorphism in women with fetal loss: First data for a Serbian population
Background: Plasminogen activator inhibitor 1 (PAI-1) is an inhibitor of fibrinolysis. The PAI-1 4G/5G polymorphism is associated with elevated plasma levels of PAI-1. Overexpression of PAI-1 and impaired fibrinolysis in homozygous carriers of the 4G/4G PAI polymorphism may lead to abnormal placenta...
שמור ב:
| Main Authors: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Society of Medical Biochemists of Serbia, Belgrade
2014-01-01
|
| סדרה: | Journal of Medical Biochemistry |
| נושאים: | |
| גישה מקוונת: | https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2014/1452-82581402203Q.pdf |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|